{"slideshow_credits": null, "snippet": "With so many questions about its financial information unanswered, Valeant\u2019s outlook is bleak.", "abstract": null, "section_name": "Business Day", "print_page": null, "document_type": "article", "byline": {"person": [{"firstname": "Robert", "role": "reported", "lastname": "CYRAN", "rank": 1, "organization": ""}], "original": "By ROBERT CYRAN"}, "web_url": "http://www.nytimes.com/2016/03/16/business/dealbook/valeants-delay-in-filing-audited-results-adds-to-discord.html", "lead_paragraph": "With so many questions about its financial information unanswered, Valeant\u2019s outlook is bleak.", "headline": {"main": "Valeant\u2019s Delay in Filing Audited Results Adds to Discord", "content_kicker": "Breakingviews", "kicker": "Breakingviews"}, "_id": "56e852e638f0d85c820e631f", "word_count": "421", "multimedia": [], "pub_date": "2016-03-16T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "subject", "value": "Company Reports", "is_major": "N", "rank": "1"}, {"name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "is_major": "N", "rank": "2"}, {"name": "persons", "value": "Pearson, John Michael (1959- )", "is_major": "N", "rank": "3"}], "blog": [], "subsection_name": "DealBook", "type_of_material": "News"}